Aaron J. Kosar

Array ( [id] => 4839367 [patent_doc_number] => 20080279852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Methods of treatment with glycosylated antibodies' [patent_app_type] => utility [patent_app_number] => 12/122123 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8227 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279852.pdf [firstpage_image] =>[orig_patent_app_number] => 12122123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8351631 [patent_doc_number] => 08246958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies' [patent_app_type] => utility [patent_app_number] => 12/175116 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 20593 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12175116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410892 [patent_doc_number] => 20090124791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'IDENTIFICATION OF UNIQUE BINDING INTERACTIONS BETWEEN CERTAIN ANTIBODIES AND THE HUMAN B7.1 AND B7.2 CO-STIMULATORY ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/171871 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18748 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124791.pdf [firstpage_image] =>[orig_patent_app_number] => 12171871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454533 [patent_doc_number] => 20100189721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/667899 [patent_app_country] => US [patent_app_date] => 2008-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11008 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189721.pdf [firstpage_image] =>[orig_patent_app_number] => 12667899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758893 [patent_doc_number] => 20080311119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/139362 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22231 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311119.pdf [firstpage_image] =>[orig_patent_app_number] => 12139362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134441 [patent_doc_number] => 20110008343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation' [patent_app_type] => utility [patent_app_number] => 12/663450 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12287 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008343.pdf [firstpage_image] =>[orig_patent_app_number] => 12663450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323473 [patent_doc_number] => 20090061463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'P-Selectin associated with Eosinophils as a marker for asthma and correlating with B-1 integrin activation' [patent_app_type] => utility [patent_app_number] => 12/129317 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16307 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061463.pdf [firstpage_image] =>[orig_patent_app_number] => 12129317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6380067 [patent_doc_number] => 20100316632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'MEANS AND METHODS FOR ENHANCING DIFFERENTIATION OF HAEMATOPOIETIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 12/600003 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11805 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316632.pdf [firstpage_image] =>[orig_patent_app_number] => 12600003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262837 [patent_doc_number] => 20100297154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen' [patent_app_type] => utility [patent_app_number] => 12/151908 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41768 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297154.pdf [firstpage_image] =>[orig_patent_app_number] => 12151908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339997 [patent_doc_number] => 20100247537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ADJUVANT COMBINATIONS OF NKT ACTIVATOR, CD40 AGONIST, AND OPTIONAL ANTIGEN, THE USE THROUGH INDUCING SYNERGISTIC CELLULAR IMMUNITY' [patent_app_type] => utility [patent_app_number] => 12/597615 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7972 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247537.pdf [firstpage_image] =>[orig_patent_app_number] => 12597615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177523 [patent_doc_number] => 07655230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Co-administration of a tissue plasminogen activator, anti-CD11b antibody and anti-CD18 antibody in stroke' [patent_app_type] => utility [patent_app_number] => 12/107050 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12636 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655230.pdf [firstpage_image] =>[orig_patent_app_number] => 12107050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4431932 [patent_doc_number] => 07897149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Fully human anti-VAP-1 monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 12/081707 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 15103 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897149.pdf [firstpage_image] =>[orig_patent_app_number] => 12081707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291170 [patent_doc_number] => 20090023900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same' [patent_app_type] => utility [patent_app_number] => 12/102818 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29294 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023900.pdf [firstpage_image] =>[orig_patent_app_number] => 12102818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91343 [patent_doc_number] => 07731966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Monoclonal antibodies against β3 integrins' [patent_app_type] => utility [patent_app_number] => 12/082686 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 6269 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/731/07731966.pdf [firstpage_image] =>[orig_patent_app_number] => 12082686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960569 [patent_doc_number] => 20080274994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'CARDIAC MYOSIN LIGHT CHAIN KINASE AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/101812 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27591 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274994.pdf [firstpage_image] =>[orig_patent_app_number] => 12101812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839363 [patent_doc_number] => 20080279848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Methods of treating lupus using CD4 antibodies' [patent_app_type] => utility [patent_app_number] => 12/077934 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 36024 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279848.pdf [firstpage_image] =>[orig_patent_app_number] => 12077934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412453 [patent_doc_number] => 20100166748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'C5 Antigens and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/532261 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27816 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166748.pdf [firstpage_image] =>[orig_patent_app_number] => 12532261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277963 [patent_doc_number] => 20090130095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'ANTI-CD40 ANTIBODIES CAPABLE OF BLOCKING B-CELL ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/049850 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9696 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130095.pdf [firstpage_image] =>[orig_patent_app_number] => 12049850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336770 [patent_doc_number] => 20090053234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents' [patent_app_type] => utility [patent_app_number] => 12/048738 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 75676 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053234.pdf [firstpage_image] =>[orig_patent_app_number] => 12048738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718656 [patent_doc_number] => 20080241178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'NOVEL HUMAN GENE FUNCTIONALLY RELATED TO DYSLEXIA' [patent_app_type] => utility [patent_app_number] => 12/045602 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9039 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241178.pdf [firstpage_image] =>[orig_patent_app_number] => 12045602 [rel_patent_id] =>[rel_patent_doc_number] =>)